Associate Director Value & Access Strategy Skeletal Conditions

Pay 100-130/h depending on experience We are seeking a US Market Access Launch Readiness Support Contractor to shape and deliver critical pre‑launch market access deliverables for the Hypochondroplasia (HCH) launch, while ensuring strategic alignment across our broader skeletal conditions portfolio, including Achondroplasia (ACH). This is a high‑impact role demanding both strategic thinking and disciplined execution. As a key partner to the Senior Director, you will provide coordination oversight, cross‑functional leadership, and direct execution accountability to secure Day‑1 access for Voxzogo in the HCH indication. Core Responsibilities Launch Readiness Project Management Orchestrate the US Market Access HCH Launch workplan, driving milestone accountability across all workstreams — from payer readiness to Day‑1 patient support services activation. Actively manage the launch critical path, identifying execution risks and leading mitigation efforts to protect Day‑1 access commitments. Serve as the central coordination point across internal teams and external partners, ensuring workstream interdependencies are visible and managed proactively. Maintain a launch readiness dashboard to provide real‑time visibility into workstream progress, milestone status, and risk flags, enabling rapid decision‑making. Payer Value & Asset Development Support the development and refinement of the Pre‑Approval Payer Value Deck, synthesizing complex clinical and economic evidence into a clear, compelling narrative for payer engagements to ensure payer readiness. Manage the end‑to‑end MMRC/PRB submission and review process for all payer‑facing HCH assets. Support strategic material development, logistical oversight, and insight synthesis for the upcoming Payer Ad Board in collaboration with external vendors and internal stakeholders. Launch Readiness Pull‑through Oversee operational alignment across V&A Strategy, Patient Support Services, Pricing & Contracting, and Distribution Channels team to ensure frictionless access for providers and patients upon product launch. Oversee pull‑through readiness across payers, providers, hubs, specialty pharmacies, and distributors — ensuring no gaps at the point of patient access. Serve as a hands‑on strategic resource for ad‑hoc initiatives as they emerge across the launch lifecycle, flexing capacity to address high‑priority needs across market‑access workstreams in real time. Qualifications & Experience Market Access Expertise: 7+ years in US Biotech/Pharma with deep experience in Payer Marketing, Patient Support Services, Pricing and Contracting Strategy, HEOR, and/or Launch Excellence. Portfolio Complexity: Proven ability to manage access strategies for multiple indications or products simultaneously. Launch Execution: Direct experience managing the ‘critical window’ of pre‑approval deliverables and Day‑1 readiness. Cross‑functional Leadership: Ability to collaborate and contextualize trade‑offs with medical, legal, and regulatory for MMRC/PRB reviews. Communication: Exceptional ability to translate clinical and economic data into payer value communications and strategy documents. Vendor Management: Experience managing external agencies and vendors end‑to‑end — including scoping, contracting, directing deliverables, and ensuring on‑time, on‑strategy outputs. Rare Disease / Specialty Experience: Familiarity with rare or ultra‑rare disease access dynamics is preferred. The Impact In this role, you will be the primary driver of the execution steps that define our market success. By closing the gap on critical pre‑approval deliverables, you ensure our breakthrough therapy is positioned for immediate uptake and long‑term success. #J-18808-Ljbffr Planet Pharma Group